1. Patterns of Self-Reported Symptoms in Pancreatic Cancer Patients Receiving Chemoradiation 
Cielito C. Reyes-Gibby, DrPH, Wenyaw Chan, PhD, James L. Abbruzzese, MD, Henry Q. Xiong, MD, Linus Ho, MD, Douglas B. Evans, MD, Gauri Varadhachary, MD, Samrat Bhat, MBBS, Robert A. Wolff, MD, Christopher Crane, MD 
Journal of Pain and Symptom Management 
Volume 34, Issue 3, Pages (September 2007)
DOI: /j.jpainsymman
Copyright © 2007 U.S. Cancer Pain Relief Committee Terms and Conditions

2. Fig. 1
Mean score of symptoms assessed before chemoradiation (Note: all symptom items were assessed using an 11-point (0=none; 10=as bad as you can imagine) numeric rating scale).
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2007 U.S. Cancer Pain Relief Committee Terms and Conditions

3. Fig. 2
Prevalence of moderate to severe symptoms (≥5, on a 0–10 scale) before, during, and after chemoradiotherapy (n=43) (Note: all symptom items were statistically significant (P<0.001) for McNemar test for paired binary response before and after chemoradiation (n=27). No statistically significant (P>0.05) differences for survival and disease progression for patients with complete data versus those with missing data. Prevalence during treatment was computed as any report of >5 symptom severity during the chemoradiation period).
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2007 U.S. Cancer Pain Relief Committee Terms and Conditions